The Cancer Research UK Clinical Trials Unit (CRCTU) is one of the largest cancer trials units in the UK and has been in existence for more than 30 years. It was one of the first NCRI accredited units and is a UKCRN registered trials unit. The CRCTU is one of three trials units at the University of Birmingham that form the Birmingham Centre for Clinical Trials. The CRCTU is also an integral part of the Birmingham Experimental Cancer Medicine Centre and the Birmingham Cancer Research UK Cancer Centre. The unit receives core funding from Cancer Research UK . 

The CRCTU specialise in the design, conduct and analysis of phase I to IV cancer clinical trials for Investigators nationwide and internationally in a number of specialist areas including but not limited to:

  • Breast cancer
  • Gastrointestinal cancer
  • Gynaecological cancer
  • Haematological cancer
  • Hepatobiliary cancer
  • Lung cancer
  • Paediatric cancer
  • Sarcoma
  • Skin cancer
  • Supportive care
  • Urological cancer

The CRCTU has experience in trials involving:

  • Investigational medicinal products, including first in man studies
  • Radiotherapy
  • Devices
  • Surgery
  • Allogenic stem cell transplantation
  • Gene therapy
  • Immunotherapy
  • Biomarkers

For more information download the CRCTU Leaflet